Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach pain is one of the most commonly reported side effects of Wegovy (semaglutide). It usually appears in the first few days after a new dose, tends to ease within a week or two as your body adjusts, and is rarely a sign of anything serious — though a small number of people do need medical attention. Here is what the evidence says about why it happens and how to manage it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've just administered your second Wegovy pen, and by the next morning there's a dull ache sitting across the middle of your abdomen. You eat your usual breakfast and it gets noticeably worse. The instinct is to worry something is wrong. Most of the time, it isn't.
Wegovy works by mimicking GLP-1, a gut hormone that tells your brain you're full and slows the rate at which food moves out of your stomach, and you can read more about how Wegovy works in the stomach if you want a closer look at that process. That slowing (called delayed gastric emptying) is central to how the medicine reduces appetite. But it also means food sits in the stomach longer than it used to, and the stomach wall has to work harder to process it. The result, for many people, is cramping, pressure or a generalised ache that feels worse after eating.
This pattern is especially pronounced in the first week after a new dose. The semaglutide information page outlines the full titration schedule — doses step up gradually precisely to let your gut adapt. Most people find the discomfort peaks around 24 to 48 hours after the injection and then fades. By the time the next dose is due, things usually feel considerably better. That rhythm repeats, more mildly, with each dose increase, and stops entirely for most people once they reach and settle at their maintenance dose.
The NHS guidance on tirzepatide and semaglutide both confirm that gastrointestinal effects are the most common category of side effect with this class of medicine, and that they are typically mild to moderate and transient.
There is a common misconception that stomach pain on Wegovy is simply something you endure until your body catches up. Eating behaviour makes a real difference. When gastric emptying is already slowed, adding a large, high-fat meal is essentially asking an already-working stomach to take on substantially more. The discomfort that follows is predictable.
Practical adjustments that consistently help: eating smaller portions spread across more meals rather than two or three large ones; putting the fork down between bites; avoiding fried or very fatty foods during the early weeks; and staying well hydrated, particularly if nausea is also present. Alcohol and carbonated drinks can worsen bloating and cramping on top of the medicine's effect, so many people find it useful to cut back, at least temporarily.
If you are looking for more specific tactics, there is a dedicated page on how to reduce stomach pain on Wegovy with practical, evidence-based suggestions. The short version: the stomach is adapting to a new hormonal signal, treating it gently during that period significantly reduces how much pain you experience.
Protein and fibre also matter here. Wegovy reduces overall appetite, and some people eat so little that they under-eat protein, which can compound fatigue alongside the GI symptoms. Keeping protein intake adequate makes the overall experience considerably more manageable.
Not every stomach pain on Wegovy is the ordinary adjustment kind. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis (inflammation of the pancreas) as a known, though infrequent, risk. The symptom pattern to watch for is distinct: severe pain in the upper abdomen that spreads to the back, often with vomiting, and that does not settle within a few hours or improve with rest and hydration.
That is a different presentation from the cramping and bloating most people describe. Pancreatitis pain tends to be sharper, more constant and doesn't ease after a bowel movement or passing wind. If you experience it, seek medical attention the same day. Do not wait to see whether the next dose might be different.
Gallbladder symptoms are another category: pain in the upper right abdomen, sometimes after eating fatty foods, occasionally with fever. Gallstones occur more frequently in people who lose weight rapidly, and GLP-1 medicines have been associated with an increased gallbladder risk in trial data. Again, worth getting checked rather than managing at home.
For a fuller breakdown of the different pain types and how they present, the Wegovy stomach pain guide covers the distinctions in more detail. If you are uncertain whether your symptoms fall into the ordinary or urgent category, that is exactly the question to raise with a prescriber rather than try to answer alone.
Stomach pain by itself is not a reason to stop Wegovy. It is, however, a legitimate reason to have a conversation with your prescriber about whether your current dose is right for now. For some people, the pain at a given dose level is severe enough that staying at it for a few extra weeks (rather than titrating up on schedule) is the smarter clinical choice. That is a decision a prescriber makes with you, based on your actual experience.
What a prescriber should never do is simply tell you to push through without any support. If your stomach pain is persistent, waking you at night, or affecting your ability to eat adequately, that needs clinical input. The FAQ section covers some of the most common questions patients bring to our team about managing side effects, and our support team is available seven days a week for aftercare queries.
Wegovy is a prescription-only medicine dispensed following clinical assessment, the prescriber who reviews your case is the right person to guide you on dose timing, not a forum thread. If you are considering starting treatment and want to understand what ongoing clinical support looks like, you can find out more about weight-loss treatment options or review what Wegovy costs privately before beginning a consultation. Speak to our prescribers if stomach pain is one of your main concerns before starting, it's a conversation worth having upfront.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.